Cargando…
Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Breast Cancer Diagnosis
PURPOSE: There is an urgent need for new biomarkers for the diagnosis of breast cancer. Exosomes can communicate with cells through transport molecules, including long-chain noncoding RNA (lncRNA), which is considered as a promising noninvasive biomarker. Here, we aimed to determine the potential of...
Autores principales: | Zhong, Guobin, Wang, Keqiong, Li, Jiawei, Xiao, Shuzhe, Wei, Wei, Liu, Jianlun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109356/ https://www.ncbi.nlm.nih.gov/pubmed/32273726 http://dx.doi.org/10.2147/OTT.S243601 |
Ejemplares similares
-
H19 Knockdown Suppresses Proliferation and Induces Apoptosis by Regulating miR-130a-3p/SATB1 in Breast Cancer Cells
por: Zhong, Guobin, et al.
Publicado: (2020) -
Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis
por: Wang, Jiansong, et al.
Publicado: (2018) -
Tumor-to-Gland Volume Ratio versus Tumor-to-Breast Ratio as Measured on CBBCT: Possible Predictors of Breast-Conserving Surgery
por: Li, Jiawei, et al.
Publicado: (2021) -
Serum exosome microRNA panel as a noninvasive biomarker for molecular diagnosis of fulminant myocarditis
por: Zhang, Yingying, et al.
Publicado: (2020) -
Urinary exosomal long non-coding RNAs as noninvasive biomarkers for diagnosis of bladder cancer by RNA sequencing
por: Bian, Bingxian, et al.
Publicado: (2022)